Promoting Atrial Fibrillation Screening in Primary Care

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorSun Yat-sen University

About this trial

Atrial fibrillation is the most common sustained cardiac arrhythmia in adults. Due to the asymptomatic and paroxysmal nature (randomly and shortly occurring of atrial fibrillation, and can therefore remain unnoticed) of atrial fibrillation. Atrial fibrillation increases the risk of stroke five fold if left untreated.

Screening in old populations above age 65 years is helpful to find more atrial fibrillation cases. However, screening for atrial fibrillation is not well implemented in China. Thus, this project aims to promote atrial fibrillation screening in primary care centers in China. We will develop an intervention program (SEARCH-AF) and examine the effects (including the clinical effects and implementation effects) of program.

Eligibility criteria

Qualifiers

aged 65 years or above

living in community

Disqualifiers

with a previous confirmed diagnosis of atrial fibrillation

with implanted ICD or pacemaker

unable to provide consent

involving in other atrial fibrillation screening program

Trial design

Treatments tested in this trial

  • SEARCH-AF

Treatment groups

4,800 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators